X-136497775-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014500.5(HTATSF1):āc.91C>Gā(p.Gln31Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000917 in 1,090,333 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014500.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTATSF1 | ENST00000218364.5 | c.91C>G | p.Gln31Glu | missense_variant | Exon 1 of 9 | 1 | NM_014500.5 | ENSP00000218364.4 | ||
HTATSF1 | ENST00000535601.5 | c.91C>G | p.Gln31Glu | missense_variant | Exon 2 of 10 | 1 | ENSP00000442699.1 | |||
HTATSF1 | ENST00000448450.5 | c.91C>G | p.Gln31Glu | missense_variant | Exon 2 of 6 | 5 | ENSP00000411381.1 | |||
HTATSF1 | ENST00000425695.5 | c.91C>G | p.Gln31Glu | missense_variant | Exon 2 of 6 | 3 | ENSP00000412420.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 exomes AF: 0.00000556 AC: 1AN: 179908Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64636
GnomAD4 exome AF: 9.17e-7 AC: 1AN: 1090333Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 357049
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.91C>G (p.Q31E) alteration is located in exon 2 (coding exon 1) of the HTATSF1 gene. This alteration results from a C to G substitution at nucleotide position 91, causing the glutamine (Q) at amino acid position 31 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at